These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34742999)

  • 21. [Efficacy of continuation and maintenance electroconvulsive therapy (c/m ECT) in the treatment of patients with therapy-resistant affective disorders: a retrospective analysis].
    Post T; Kemmler G; Krassnig T; Brugger A; Hausmann A
    Neuropsychiatr; 2015; 29(3):133-8. PubMed ID: 26092747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroconvulsive Therapy for the Treatment of Severe Mood Disorders During Adolescence: A Retrospective Chart Review.
    Ghaziuddin N; Shamseddeen W; Gettys G; Ghaziuddin M
    J Child Adolesc Psychopharmacol; 2020 May; 30(4):235-243. PubMed ID: 32125885
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of Previous Electroconvulsive Therapy on Subsequent Response to Transcranial Magnetic Stimulation for Major Depressive Disorder.
    Yuan S; Tirrell E; Gobin AP; Carpenter LL
    Neuromodulation; 2020 Apr; 23(3):393-398. PubMed ID: 31588659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The benefits and costs of changing treatment technique in electroconvulsive therapy due to insufficient improvement of a major depressive episode.
    Sackeim HA; Prudic J; Devanand DP; Nobler MS; Haskett RF; Mulsant BH; Rosenquist PB; McCall WV
    Brain Stimul; 2020; 13(5):1284-1295. PubMed ID: 32585354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Impact of COVID-19 on Electroconvulsive Therapy: A Multisite, Retrospective Study From the Clinical Alliance and Research in Electroconvulsive Therapy and Related Treatments Network.
    Kwan E; Le B; Loo CK; Dong V; Tor PC; Davidson D; Mohan T; Waite S; Branjerdporn G; Sarma S; Hussain S; Martin DM
    J ECT; 2022 Mar; 38(1):45-51. PubMed ID: 34387286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Borderline personality traits do not influence response to TMS.
    Ward HB; Yip A; Siddiqui R; Morales OG; Seiner SJ; Siddiqi SH
    J Affect Disord; 2021 Feb; 281():834-838. PubMed ID: 33229022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: delayed response after electroconvulsive therapy in a patient with major depressive disorder.
    Chen F; Sidhom E; Yang S; Ruiz-Mendoza E; Essem J
    BMC Psychiatry; 2021 Jan; 21(1):50. PubMed ID: 33478427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-level Characteristics and Inequitable Access to Inpatient Electroconvulsive Therapy for Depression: A Population-based Cross-sectional Study: Caractéristiques au niveau du patient et accès inéquitable à la thérapie électroconvulsive pour patients hospitalisés.
    Kaster TS; Blumberger DM; Gomes T; Sutradhar R; Dasklakis ZJ; Wijeysundera DN; Vigod SN
    Can J Psychiatry; 2021 Feb; 66(2):147-158. PubMed ID: 32613857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroconvulsive Therapy (ECT) for Refractory Psychiatric Symptoms in Huntington's Disease: A Case Series and Review of the Literature.
    Adrissi J; Nadkarni NA; Gausche E; Bega D
    J Huntingtons Dis; 2019; 8(3):291-300. PubMed ID: 31322579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of vascular risk factors on clinical outcome in elderly patients with depression receiving electroconvulsive therapy.
    Jurek L; Dorey JM; Nourredine M; Galvao F; Brunelin J
    J Affect Disord; 2021 Jan; 279():308-315. PubMed ID: 33096329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse following electroconvulsive therapy.
    Moksnes KM
    Tidsskr Nor Laegeforen; 2011 Oct; 131(20):1991-3. PubMed ID: 22016123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness.
    Shelef A; Mazeh D; Berger U; Baruch Y; Barak Y
    J ECT; 2015 Jun; 31(2):125-8. PubMed ID: 25373561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do benzodiazepines moderate the effectiveness of bitemporal electroconvulsive therapy in major depression?
    Gálvez V; Loo CK; Alonzo A; Cerrillo E; Menchón JM; Crespo JM; Urretavizcaya M
    J Affect Disord; 2013 Sep; 150(2):686-90. PubMed ID: 23668903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive remediation following electroconvulsive therapy in patients with treatment resistant depression: randomized controlled trail of an intervention for relapse prevention - study protocol.
    Van de Velde N; Kappen M; Koster EHW; Hoorelbeke K; Tandt H; Verslype P; Baeken C; De Raedt R; Lemmens G; Vanderhasselt MA
    BMC Psychiatry; 2020 Sep; 20(1):453. PubMed ID: 32938410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression.
    Vanicek T; Kranz GS; Vyssoki B; Fugger G; Komorowski A; Höflich A; Saumer G; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Brain Stimul; 2019; 12(4):1041-1050. PubMed ID: 31000384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressive Symptom Dimensions in Treatment-Resistant Major Depression and Their Modulation With Electroconvulsive Therapy.
    Wade BSC; Hellemann G; Espinoza RT; Woods RP; Joshi SH; Redlich R; Jørgensen A; Abbott CC; Oedegaard KJ; McClintock SM; Oltedal L; Narr KL
    J ECT; 2020 Jun; 36(2):123-129. PubMed ID: 31464814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Electroconvulsive Therapy in Adolescents With Treatment-Resistant Depressive Disorders: A Case Series.
    Zhand N; Courtney DB; Flament MF
    J ECT; 2015 Dec; 31(4):238-45. PubMed ID: 25830809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anticholinergic burden is not associated with cognitive impairments in patients treated by electroconvulsive therapy for treatment-resistant depression.
    Laurin A; Bonjour M; Galvao F; Dubien Berbey C; Sauvaget A; Bulteau S
    J Psychiatr Res; 2022 Jun; 150():87-95. PubMed ID: 35366599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When Can We Predict the Outcome of an Electroconvulsive Therapy Course in Adolescents?: A Retrospective Study.
    Maoz H; Nitzan U; Goldwyn Y; Krieger I; Bloch Y
    J ECT; 2018 Jun; 34(2):104-107. PubMed ID: 29219862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.